FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801

Fuminori Yamaguchi, Yuko Hirata, Hossain Akram, Kazuyo Kamitori, Youyi Dong, Li Sui, Masaaki Tokuda

Open source

DOI
10.1186/1471-2407-13-468
Published
2013-10-10
Container
BMC Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

limited evidence Score 46/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/1471-2407-13-468,
  title = {FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801},
  author = {Fuminori Yamaguchi and Yuko Hirata and Hossain Akram and Kazuyo Kamitori and Youyi Dong and Li Sui and Masaaki Tokuda},
  year = {2013},
  journal = {BMC Cancer},
  doi = {10.1186/1471-2407-13-468},
  url = {https://doi.org/10.1186/1471-2407-13-468}
}

RIS

TY  - JOUR
TI  - FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
AU  - Fuminori Yamaguchi
AU  - Yuko Hirata
AU  - Hossain Akram
AU  - Kazuyo Kamitori
AU  - Youyi Dong
AU  - Li Sui
AU  - Masaaki Tokuda
PY  - 2013
JO  - BMC Cancer
DO  - 10.1186/1471-2407-13-468
UR  - https://doi.org/10.1186/1471-2407-13-468
ER  - 

APA

Yamaguchi, F., Hirata, Y., Akram, H., Kamitori, K., Dong, Y., Sui, L., & Tokuda, M. (2013). FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer. https://doi.org/10.1186/1471-2407-13-468

Source records